Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study
Volume 38 - Issue 3 - September 2023, Page 477-479
Meltem Alkan Melikoğlu

Enter the code above.